Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Tagliati

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Journal of the Neurological Sciences|April 23, 2017
Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registryRichard M Trosch, Alberto J Espay, Daniel Truong, et al.
The New England Journal of Medicine|January 27, 2006
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi JewsLaurie J Ozelius, Geetha Senthil, Rachel Saunders-Pullman, et al.
Neuromodulation : Journal of the International Neuromodulation Society|August 30, 2014
The rationale driving the evolution of deep brain stimulation to constant-current devicesJeff M Bronstein, Michele Tagliati, Cameron McIntyre, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2020
Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysisCarlo Alberto Artusi, Alok Dwivedi, Alberto Romagnolo, et al.
Journal of Neurology|March 3, 2011
Factors predicting protracted improvement after pallidal DBS for primary dystonia: the role of age and disease durationIoannis U Isaias, Jens Volkmann, Andreas Kupsch, et al.
American Journal of Medical Genetics. Part A|August 21, 2007
Narrowing the DYT6 dystonia region and evidence for locus heterogeneity in the Amish-MennonitesRachel Saunders-Pullman, Deborah Raymond, Geetha Senthil, et al.
Archives of Neurology|October 13, 2010
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issuesJeff M Bronstein, Michele Tagliati, Ron L Alterman, et al.
The Lancet. Neurology|October 26, 2010
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialWilliam J Marks, Raymond T Bartus, Joao Siffert, et al.
The Lancet. Neurology|January 14, 2012
Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trialMichael S Okun, Bruno V Gallo, George Mandybur, et al.
JAMA Neurology|September 15, 2025
Five-Year Outcomes from Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson DiseasePhilip A Starr, Rajat S Shivacharan, Edward Goldberg, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Journal of the Neurological Sciences|April 23, 2017
Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registryRichard M Trosch, Alberto J Espay, Daniel Truong, et al.
The New England Journal of Medicine|January 27, 2006
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi JewsLaurie J Ozelius, Geetha Senthil, Rachel Saunders-Pullman, et al.
Neuromodulation : Journal of the International Neuromodulation Society|August 30, 2014
The rationale driving the evolution of deep brain stimulation to constant-current devicesJeff M Bronstein, Michele Tagliati, Cameron McIntyre, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2020
Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysisCarlo Alberto Artusi, Alok Dwivedi, Alberto Romagnolo, et al.
Journal of Neurology|March 3, 2011
Factors predicting protracted improvement after pallidal DBS for primary dystonia: the role of age and disease durationIoannis U Isaias, Jens Volkmann, Andreas Kupsch, et al.
American Journal of Medical Genetics. Part A|August 21, 2007
Narrowing the DYT6 dystonia region and evidence for locus heterogeneity in the Amish-MennonitesRachel Saunders-Pullman, Deborah Raymond, Geetha Senthil, et al.
Archives of Neurology|October 13, 2010
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issuesJeff M Bronstein, Michele Tagliati, Ron L Alterman, et al.
The Lancet. Neurology|October 26, 2010
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialWilliam J Marks, Raymond T Bartus, Joao Siffert, et al.
The Lancet. Neurology|January 14, 2012
Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trialMichael S Okun, Bruno V Gallo, George Mandybur, et al.
JAMA Neurology|September 15, 2025
Five-Year Outcomes from Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson DiseasePhilip A Starr, Rajat S Shivacharan, Edward Goldberg, et al.
Pageof 9